Protocol development is an essential first step in turning any research question into a study. Exisiting protocol development tools can be adapted to allow rapid, effective protocol development during the COVID-19 Pandemic.
Protocol Development Steps Provide guidance on all elements of Protocol development in addition to practical advice such as how to navigate regulations and guidelines, the importance of community engagement and tips on collaborative writing.
The 'Study Walk-through' A method to help translate your protocol into an accurate and successful study. This toolkit describes the study walkthrough approach, why it might be of benefit to your study and how you can use successfully implement the method using practical examples and 'How to' guidance.
Resources A collection of resources linked to protocol development which can be searched and filtered depending on their type.
Concept Protocol: A Mixed-Methods Platform Trial for Assessing Public Health Interventions During the COVID-19 Pandemic
This protocol is being developed by an open community of health researchers. The aim is to develop a mixed methods platform trial protocol that any research team can take and adapt and use this to evaluate their public health measures.
We welcome contributions, ideas and comments. This open platform protocol will be desgined so that can be taken and adapted in any setting. Further versions can be designed from the core platform and be finalised appropriately depending on the intervention and assessment tools.
You can view the full concept protocol in the Concept Protocol Review Tool, available here.
Use the buttons below to navigate the COVID-19 Research Implementation Hub themes
The Global Health Network is maintaining a resource bank designed to aid in the tracking and identification of ongoing trials and studies concerning COVID-19. The bank also features resources which provide access to trial materials such as protocols, data sets and publications. You can access it here
The WHO has developed the SOLIDARITY trial platform to assess potential therapies for COVID-19. The aim is for thousands of patients to be recruited globally, with standardised data capture that can be easily shared. Read more about the trial here
An international platform trial specifically designed for a pandemic period. The aim is is to generate evidence that can be applied during the COVID-19 pandemic to reduce mortality, reduce intensive care use, and reduce morbidity in severely ill patients with COVID-19 infection. Read more about the trial here